Literature DB >> 2578898

Changes in pulmonary function during and after bleomycin treatment in patients with testicular carcinoma.

P W van Barneveld, G Veenstra, D T Sleijfer, T W van der Mark, N H Mulder, H Schraffordt Koops, H J Sluiter, R Peset.   

Abstract

Pulmonary function tests, including spirometry, transfer factor of the lungs for carbon monoxide (TlCO), and the two components of TlCO, the diffusing capacity of the alveolocapillary membrane (Dm) and pulmonary capillary blood volume (Vc), were carried out in a group of patients with testicular carcinoma during and after treatment with the Einhorn regimen. The lung function parameters of patients who developed bleomycin-induced pneumonitis were compared with those recorded in a group of patients who did not develop this syndrome. We suggest that bleomycin-induced damage to the pulmonary capillary vasculature can be monitored by measuring Vc and that ensuing fibrosis can be measured by recording Dm. The decrease in Dm is probably compensated for by an increase in Vc, leading to a smaller change in TlCO.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2578898     DOI: 10.1007/bf00434359

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  14 in total

1.  Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in the human lung, with special reference to true diffusing capacity of pulmonary membrane and volume of blood in the lung capillaries.

Authors:  F J ROUGHTON; R E FORSTER
Journal:  J Appl Physiol       Date:  1957-09       Impact factor: 3.531

2.  A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide.

Authors:  W S BLAKEMORE; R E FORSTER; J W MORTON; C M OGILVIE
Journal:  J Clin Invest       Date:  1957-01       Impact factor: 14.808

3.  The diffusion of gases through the lungs of man.

Authors:  M Krogh
Journal:  J Physiol       Date:  1915-05-12       Impact factor: 5.182

4.  A clinical review of bleomycin--a new antineoplastic agent.

Authors:  R H Blum; S K Carter; K Agre
Journal:  Cancer       Date:  1973-04       Impact factor: 6.860

5.  Coronary artery disease after treatment with bleomycin and vinblastine.

Authors:  N J Vogelzang; D H Frenning; B J Kennedy
Journal:  Cancer Treat Rep       Date:  1980 Oct-Nov

6.  DLO2 in excised lungs perfused with blood containing sodium dithionite (Na2S2O4).

Authors:  B Burns; R H Shepard
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1979-01

7.  Role of pulmonary function tests in the prevention of bleomycin pulmonary toxicity during chemotherapy for metastatic testicular teratoma.

Authors:  H H Lucraft; P M Wilkinson; T B Stretton; G Read
Journal:  Eur J Cancer Clin Oncol       Date:  1982-02

8.  Bleomycin-induced changes in the carbon monoxide transfer factor of the lungs and its components.

Authors:  P B Luursema; M A Star-Kroesen; T W van der Mark; D T Sleyfer; H S Koops; R Peset
Journal:  Am Rev Respir Dis       Date:  1983-11

9.  The pathogenesis of bleomycin-induced pulmonary fibrosis in mice.

Authors:  I Y Adamson; D H Bowden
Journal:  Am J Pathol       Date:  1974-11       Impact factor: 4.307

10.  Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer.

Authors:  L H Einhorn; J Donohue
Journal:  Ann Intern Med       Date:  1977-09       Impact factor: 25.391

View more
  3 in total

Review 1.  Comparative tolerability of chemotherapy regimens for germ cell cancer.

Authors:  S Culine; J P Droz
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

2.  Pulmonary toxicity in patients with non-Hodgkin's lymphoma treated with bleomycin-containing combination chemotherapy.

Authors:  H Y Ngan; R H Liang; W K Lam; T K Chan
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

3.  Decrease in pulmonary function during bleomycin-containing combination chemotherapy for testicular cancer: not only a bleomycin effect.

Authors:  S Sleijfer; T W van der Mark; H Schraffordt Koops; N H Mulder
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.